PPARα-deficient ob/ob obese mice become more obese and manifest severe hepatic steatosis due to decreased fatty acid oxidation

American Journal of Pathology

Volumn 185, Issue 5, 2015, Pages 1396-1408

  Gao, Qian ^a,b   Jia, Yuzhi ^a   Yang, Gongshe ^b   Zhang, Xiaohong ^a   Boddu, Prajwal C ^a   Petersen, Bryon ^c   Narsingam, Saiprasad ^a   Zhu, Yi Jun ^a   Thimmapaya, Bayar ^a   Kanwar, Yashpal S ^a   Reddy, Janardan K ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWEST A F UNIVERSITY   (China)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PIRINIXIC ACID; FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; DIET; FATTY ACID OXIDATION; FATTY LIVER; MITOGENESIS; MOUSE; NONHUMAN; OB/OB MOUSE; OBESITY; PRIORITY JOURNAL; UPREGULATION; WHITE ADIPOSE TISSUE; ANIMAL; C57BL MOUSE; COMPLICATION; DEFICIENCY; DISEASE MODEL; IMMUNOBLOTTING; LIVER NEOPLASMS; METABOLISM; MOUSE MUTANT; NON-ALCOHOLIC FATTY LIVER DISEASE; OXIDATION REDUCTION REACTION; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; DISEASE MODELS, ANIMAL; FATTY ACIDS; IMMUNOBLOTTING; LIVER NEOPLASMS; MICE; MICE, INBRED C57BL; MICE, OBESE; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; OXIDATION-REDUCTION; PPAR ALPHA; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84928024639     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2015.01.018     Document Type: Article

References (59)

1. M. Ng, T. Fleming, M. Robinson, B. Thomson, N. Graetz, and C. Margono et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013 Lancet 384 2014 766 781
2. B.T. Nguyen, and L.M. Powell The impact of restaurant consumption among US adults: effects on energy and nutrient intakes Public Health Nutr 17 2014 2445 2452
3. J.K. Reddy Nonalcoholic steatosis and steatohepatitis, III: peroxisomal beta-oxidation, PPAR alpha, and steatohepatitis Am J Physiol Gastrointest Liver Physiol 281 2001 G1333 G1339
4. J.K. Reddy, and M.S. Rao Lipid metabolism and liver inflammation, II: fatty liver disease and fatty acid oxidation Am J Physiol Gastrointest Liver Physiol 290 2006 G852 G858
5. E.J. Park, J.H. Lee, G.Y. Yu, G. He, S.R. Ali, R.G. Holzer, C.H. Osterreicher, H. Takahashi, and M. Karin Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression Cell 140 2010 197 208
6. J.C. Cohen, J.D. Horton, and H.H. Hobbs Human fatty liver disease: old questions and new insights Science 332 2011 1519 1523
7. V.G. Agopian, F.M. Kaldas, J.C. Hong, M. Whittaker, C. Holt, A. Rana, A. Zarrinpar, H. Petrowsky, D. Farmer, H. Yersiz, V. Xia, J.R. Hiatt, and R.W. Busuttil Liver transplantation for nonalcoholic steatohepatitis: the new epidemic Ann Surg 256 2012 624 633
8. R.M. Evans, G.D. Barish, and Y.X. Wang PPARs and the complex journey to obesity Nat Med 10 2004 355 361
9. L. Liu, M. Mei, S. Yang, and Q. Li Roles of chronic low-grade inflammation in the development of ectopic fat deposition Mediators Inflamm 2014 2014 418185
10. T. Gurevich-Panigrahi, S. Panigrahi, E. Wiechec, and M. Los Obesity: pathophysiology and clinical management Curr Med Chem 16 2009 506 521
11. F. Tacke, T. Luedde, and C. Trautwein Inflammatory pathways in liver homeostasis and liver injury Clin Rev Allergy Immunol 36 2009 4 12
12. E. Fabbrini, S. Sullivan, and S. Klein Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications Hepatology 51 2010 679 689
13. R. Faggioni, J. Jones-Carson, D.A. Reed, C.A. Dinarello, K.R. Feingold, C. Grunfeld, and G. Fantuzzi Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor alpha and IL-18 Proc Natl Acad Sci U S A 97 2000 2367 2372
14. J. Huang, N. Viswakarma, S. Yu, Y. Jia, L. Bai, A. Vluggens, M. Cherkaoui-Malki, M. Khan, I. Singh, G. Yang, M.S. Rao, J. Borensztajn, and J.K. Reddy Progressive endoplasmic reticulum stress contributes to hepatocarcinogenesis in fatty acyl-CoA oxidase 1-deficient mice Am J Pathol 179 2011 703 713
15. P. Misra, and J.K. Reddy Peroxisome proliferator-activated receptor-alpha activation and excess energy burning in hepatocarcinogenesis Biochimie 98 2014 63 74
16. S.R. Pyper, N. Viswakarma, S. Yu, and J.K. Reddy PPARalpha: energy combustion, hypolipidemia, inflammation and cancer Nucl Recept Signal 8 2010 e002
17. F.J. Gonzalez, and Y.M. Shah PPARalpha: mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators Toxicology 246 2008 2 8
18. T. Hays, I. Rusyn, A.M. Burns, M.J. Kennett, J.M. Ward, F.J. Gonzalez, and J.M. Peters Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis Carcinogenesis 26 2005 219 227
19. P.S. Palkar, C.R. Anderson, C.H. Ferry, F.J. Gonzalez, and J.M. Peters Effect of prenatal peroxisome proliferator-activated receptor alpha (PPARalpha) agonism on postnatal development Toxicology 276 2010 79 84
20. C.Y. Fan, J. Pan, R. Chu, D. Lee, K.D. Kluckman, N. Usuda, I. Singh, A.V. Yeldandi, M.S. Rao, N. Maeda, and J.K. Reddy Hepatocellular and hepatic peroxisomal alterations in mice with a disrupted peroxisomal fatty acyl-coenzyme A oxidase gene J Biol Chem 271 1996 24698 24710
21. S.S. Lee, T. Pineau, J. Drago, E.J. Lee, J.W. Owens, D.L. Kroetz, P.M. Fernandez-Salguero, H. Westphal, and F.J. Gonzalez Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators Mol Cell Biol 15 1995 3012 3022
22. J. Huang, Y. Jia, T. Fu, N. Viswakarma, L. Bai, M.S. Rao, Y. Zhu, J. Borensztajn, and J.K. Reddy Sustained activation of PPARalpha by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice FASEB J 26 2012 628 638
23. F. Lalloyer, B. Vandewalle, F. Percevault, G. Torpier, J. Kerr-Conte, M. Oosterveer, R. Paumelle, J.C. Fruchart, F. Kuipers, F. Pattou, C. Fievet, and B. Staels Peroxisome proliferator-activated receptor alpha improves pancreatic adaptation to insulin resistance in obese mice and reduces lipotoxicity in human islets Diabetes 55 2006 1605 1613
24. Y. Zhou, X. Zhang, L. Chen, J. Wu, H. Dang, M. Wei, Y. Fan, Y. Zhang, Y. Zhu, N. Wang, M.D. Breyer, and Y. Guan Expression profiling of hepatic genes associated with lipid metabolism in nephrotic rats Am J Physiol Renal Physiol 295 2008 F662 F671
25. T. Fu, D. Mukhopadhyay, N.O. Davidson, and J. Borensztajn The peroxisome proliferator-activated receptor alpha (PPARalpha) agonist ciprofibrate inhibits apolipoprotein B mRNA editing in low density lipoprotein receptor-deficient mice: effects on plasma lipoproteins and the development of atherosclerotic lesions J Biol Chem 279 2004 28662 28669
26. T. Fu, and J. Borensztajn Simvastatin causes the formation of cholesterol-rich remnants in mice lacking apoE Biochem Biophys Res Commun 341 2006 1172 1176
27. L. Bai, Y. Jia, N. Viswakarma, J. Huang, A. Vluggens, N.E. Wolins, N. Jafari, M.S. Rao, J. Borensztajn, G. Yang, and J.K. Reddy Transcription coactivator mediator subunit MED1 is required for the development of fatty liver in the mouse Hepatology 53 2011 1164 1174
28. K. Miura, L. Yang, N. van Rooijen, D.A. Brenner, H. Ohnishi, and E. Seki Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice Hepatology 57 2013 577 589
29. Y. Jia, C. Qi, P. Kashireddi, S. Surapureddi, Y.J. Zhu, M.S. Rao, D. Le Roith, P. Chambon, F.J. Gonzalez, and J.K. Reddy Transcription coactivator PBP, the peroxisome proliferator-activated receptor (PPAR)-binding protein, is required for PPARalpha-regulated gene expression in liver J Biol Chem 279 2004 24427 24434
30. N. Viswakarma, Y. Jia, L. Bai, Q. Gao, B. Lin, X. Zhang, P. Misra, A. Rana, S. Jain, F.J. Gonzalez, Y.J. Zhu, B. Thimmapaya, and J.K. Reddy The Med1 subunit of the mediator complex induces liver cell proliferation and is phosphorylated by AMP kinase J Biol Chem 288 2013 27898 27911
31. S. Yu, K. Matsusue, P. Kashireddy, W.Q. Cao, V. Yeldandi, A.V. Yeldandi, M.S. Rao, F.J. Gonzalez, and J.K. Reddy Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression J Biol Chem 278 2003 498 505
32. C.Y. Fan, J. Pan, N. Usuda, A.V. Yeldandi, M.S. Rao, and J.K. Reddy Steatohepatitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase: implications for peroxisome proliferator-activated receptor alpha natural ligand metabolism J Biol Chem 273 1998 15639 15645
33. I. Issemann, and S. Green Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators Nature 347 1990 645 650
34. J.K. Reddy, S.K. Goel, M.R. Nemali, J.J. Carrino, T.G. Laffler, M.K. Reddy, S.J. Sperbeck, T. Osumi, T. Hashimoto, N.D. Lalwani, and M.S. Rao Transcription regulation of peroxisomal fatty acyl-CoA oxidase and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase in rat liver by peroxisome proliferators Proc Natl Acad Sci U S A 83 1986 1747 1751
35. J.L. Halaas, K.S. Gajiwala, M. Maffei, S.L. Cohen, B.T. Chait, D. Rabinowitz, R.L. Lallone, S.K. Burley, and J.M. Friedman Weight-reducing effects of the plasma protein encoded by the obese gene Science 269 1995 543 546
36. Z. Nikoozad, M.T. Ghorbanian, and A. Rezaei Comparison of the liver function and hepatic specific genes expression in cultured mesenchymal stem cells and hepatocytes Iran J Basic Med Sci 17 2014 27 33
37. B.E. Petersen, J.P. Goff, J.S. Greenberger, and G.K. Michalopoulos Hepatic oval cells express the hematopoietic stem cell marker Thy-1 in the rat Hepatology 27 1998 433 445
38. G. van den Berghe The role of the liver in metabolic homeostasis: implications for inborn errors of metabolism J Inherit Metab Dis 14 1991 407 420
39. S. Kersten, J. Seydoux, J.M. Peters, F.J. Gonzalez, B. Desvergne, and W. Wahli Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting J Clin Invest 103 1999 1489 1498
40. T. Hashimoto, W.S. Cook, C. Qi, A.V. Yeldandi, J.K. Reddy, and M.S. Rao Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting J Biol Chem 275 2000 28918 28928
41. H.K. Park, and R.S. Ahima Leptin signaling F1000Prime Rep 6 2014 73
42. J.K. Reddy, and T. Hashimoto Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system Annu Rev Nutr 21 2001 193 230
43. Y.T. Zhou, M. Shimabukuro, K. Koyama, Y. Lee, M.Y. Wang, F. Trieu, C.B. Newgard, and R.H. Unger Induction by leptin of uncoupling protein-2 and enzymes of fatty acid oxidation Proc Natl Acad Sci U S A 94 1997 6386 6390
44. M. Shimabukuro, K. Koyama, G. Chen, M.Y. Wang, F. Trieu, Y. Lee, C.B. Newgard, and R.H. Unger Direct antidiabetic effect of leptin through triglyceride depletion of tissues Proc Natl Acad Sci U S A 94 1997 4637 4641
45. M. Maffei, H. Fei, G.H. Lee, C. Dani, P. Leroy, Y. Zhang, R. Proenca, R. Negrel, G. Ailhaud, and J.M. Friedman Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus Proc Natl Acad Sci U S A 92 1995 6957 6960
46. M. Guerre-Millo, P. Gervois, E. Raspe, L. Madsen, P. Poulain, B. Derudas, J.M. Herbert, D.A. Winegar, T.M. Willson, J.C. Fruchart, R.K. Berge, and B. Staels Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity J Biol Chem 275 2000 16638 16642
47. Y. Lee, X. Yu, F. Gonzales, D.J. Mangelsdorf, M.Y. Wang, C. Richardson, L.A. Witters, and R.H. Unger PPAR alpha is necessary for the lipopenic action of hyperleptinemia on white adipose and liver tissue Proc Natl Acad Sci U S A 99 2002 11848 11853
48. L. Orci, W.S. Cook, M. Ravazzola, M.Y. Wang, B.H. Park, R. Montesano, and R.H. Unger Rapid transformation of white adipocytes into fat-oxidizing machines Proc Natl Acad Sci U S A 101 2004 2058 2063
49. J.M. Ye, P.J. Doyle, M.A. Iglesias, D.G. Watson, G.J. Cooney, and E.W. Kraegen Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation Diabetes 50 2001 411 417
50. M.Y. Wang, Y. Lee, and R.H. Unger Novel form of lipolysis induced by leptin J Biol Chem 274 1999 17541 17544
51. Y.T. Zhou, Z.W. Wang, M. Higa, C.B. Newgard, and R.H. Unger Reversing adipocyte differentiation: implications for treatment of obesity Proc Natl Acad Sci U S A 96 1999 2391 2395
52. P.D. Gluckman, K.A. Lillycrop, M.H. Vickers, A.B. Pleasants, E.S. Phillips, A.S. Beedle, G.C. Burdge, and M.A. Hanson Metabolic plasticity during mammalian development is directionally dependent on early nutritional status Proc Natl Acad Sci U S A 104 2007 12796 12800
53. M.H. Vickers, P.D. Gluckman, A.H. Coveny, P.L. Hofman, W.S. Cutfield, A. Gertler, B.H. Breier, and M. Harris Neonatal leptin treatment reverses developmental programming Endocrinology 146 2005 4211 4216
54. E.S. Garratt, M.H. Vickers, P.D. Gluckman, M.A. Hanson, G.C. Burdge, and K.A. Lillycrop Tissue-specific 5' heterogeneity of PPARalpha transcripts and their differential regulation by leptin PLoS One 8 2013 e67483
55. I.J. Fox, and J. Roy-Chowdhury Hepatocyte transplantation J Hepatol 40 2004 878 886
56. A. Jochheim-Richter, U. Rudrich, D. Koczan, T. Hillemann, S. Tewes, M. Petry, A. Kispert, A.D. Sharma, F. Attaran, M.P. Manns, and M. Ott Gene expression analysis identifies novel genes participating in early murine liver development and adult liver regeneration Differentiation 74 2006 167 173
57. M. Golding, C.E. Sarraf, E.N. Lalani, T.V. Anilkumar, R.J. Edwards, P. Nagy, S.S. Thorgeirsson, and M.R. Alison Oval cell differentiation into hepatocytes in the acetylaminofluorene-treated regenerating rat liver Hepatology 22 1995 1243 1253
58. B.E. Petersen, V.F. Zajac, and G.K. Michalopoulos Hepatic oval cell activation in response to injury following chemically induced periportal or pericentral damage in rats Hepatology 27 1998 1030 1038
59. R.A. Davies, B. Knight, Y.W. Tian, G.C. Yeoh, and J.K. Olynyk Hepatic oval cell response to the choline-deficient, ethionine supplemented model of murine liver injury is attenuated by the administration of a cyclo-oxygenase 2 inhibitor Carcinogenesis 27 2006 1607 1616